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Abstract.
We explore the effects of three dimensional (3D) tumour structures on depth
dependent fluence rates, photodynamic doses (PDD) and fluorescence images through
Monte Carlo radiation transfer modelling (MCRT) of photodynamic therapy (PDT).
The aim with this work was to compare the commonly used uniform tumour densities
with non-uniform densities to determine the importance of including 3D models in
theoretical investigations. It was found that fractal 3D models resulted in deeper
penetration on average of therapeutic radiation and higher PDD. An increase in
effective treatment depth of 1 mm was observed for one of the investigated fractal
structures, when comparing to the equivalent smooth model. Wide field fluorescence
images were simulated, revealing information about the relationship between tumour
structure and the appearance of the fluorescence intensity. Our models indicate that
the 3D tumour structure strongly affects the spatial distribution of therapeutic light,
the PDD and the wide field appearance of surface fluorescence images.
1. Introduction and Background
Photodynamic therapy (PDT) utilises the interaction between light, molecular oxygen
and a photosensitiser, to achieve selective tissue destruction through the production
of singlet oxygen. PDT is a common method of topically treating non-melanoma
skin cancer (NMSC) and precancerous lesions such as Aktinic Keratosis (AK). The
non-invasive nature of the treatment and the good cosmetic outcome makes this
method an attractive option when treating superficial skin lesions. For topical PDT,
a cream containing either 5-aminolaevulinic acid (ALA) or its methyl ester, methyl
aminolevulinate (MAL) is added to the surface of the lesion. The cream subsequently
diffuses through the skin and is converted to the photosensitive molecule Protoporphyrin
2IX (PpIX). PpIX is produced at a higher rate by lesional cells, resulting in selective
accumulation and localisation (Wachowska et al., 2011; Darlenski and Fluhr, 2012;
Castano et al., 2004; Wilson and Patterson, 2008). PpIX absorbs light over a wide
range of wavelengths, hence there is a range of different suitable light sources. The
Aktilite is a red light emitting diode (LED) based light source commonly adopted for
conventional PDT (Moseley, 2005), and is considered in this work.
To further investigate the light interaction with skin tissue during PDT, theoretical
models are beneficial.The work presented here provides an extension of previously
published work by our group (Campbell et al., 2015a). Monte Carlo radiation transfer
(MCRT) modelling is commonly regarded as a useful tool for theoretical interpretation
of PDT (Binzoni et al., 2008; Zhu and Liu, 2013; Swartling et al., 2003; Prahl et al.,
1989). To our knowledge the majority of existing MCRT models simulating PDT assume
uniform distributions of skin tissue (Zhu and Liu, 2013). Some models introduce layers
of different tissue types and/or tumours represented by geometric shapes (Campbell
et al., 2015a; Binzoni et al., 2008; Lister et al., 2014, 2012b; Jacques, 2010; Wang
et al., 1995; Meglinski and Matcher, 2003). Three dimensional (3D) MCRT models
have however previously been introduced when studying brain tissue (Boas et al.,
2002) and blood vessel networks (Davis et al., 2011). Here we introduce 3D tumour
structures into theoretical simulations of PDT where the mass of the tumour has
been redistributed in a clustered manner. The fluence rate, photo-toxicity and surface
fluorescence images are compared for different clustered structures with a corresponding
smooth uniform model. Even though 3D voxel based MCRT models have been adopted
to study light distribution through tissue containing different 3D structures (Pfefer et al.,
1996; Patwardhan et al., 2005; Baran and Foster, 2014), to our knowledge this is the
first attempt in introducing heterogeneous skin tumour tissue where the importance of
including these features is explored.
2. Methods
MCRT modelling utilises the probabilistic nature of photon interactions to simulate
scattering, absorption and propagation of light through highly scattering media. When
a photon travelling through skin tissue reaches an interaction location, it can either be
scattered or absorbed. The probability of the different events are determined by the
optical properties (scattering and absorption coefficients) of the medium in which the
photon is travelling (Prahl et al., 1989; Swartling et al., 2003; Premru et al., 2013). Due
to the requirements of dealing with heterogeneous media, multiple anisotropic scattering
and boundary effects, MCRT modelling is a preferred modelling technique compared to
other radiation transfer techniques such as the diffusion approximation. The code that
was used throughout this work was developed from a publicly available FORTRAN code
(Wood, 2013; Wood and R. J. Reynolds, 1999). The original code was developed for
astronomy applications, but was subsequently adapted for simulating PDT and has been
extensively validated (Campbell et al., 2015a,b; Valentine et al., 2011a, 2013; Valentine,
32011).
Figure 1: a)The MCRT simulation employs a 3D cartesian grid (100 grid cells on a side)
which is illuminated from above. The optical properties are specified in each individual
voxel. A cylindrical tumour is added in the centre of the grid, in which the PpIX is
accumulated. For the non-uniform model the density of the tumour was redistributed
within the cylinder. For the uniform model the density of the tumour was assumed to
be uniform and the total tumour mass was assumed to be equal for all models. The
concentration of the PpIX was assumed be proportional to that of the tumour. The
dimensions of the grid were 10 mm on a side and the tumour was assumed to have a
6 mm diameter with a depth of 5 mm. b) Figure showing the absorption coefficient
of PpIX (dashed). The absorption coefficient is concentration dependent and for this
simulation we assume an initial average number density of PpIX molecules corresponding
to 7.84× 1013 cm−3.(Valentine, 2011; Valentine et al., 2013). The figure also shows the
light spectrum of the Aktilite (solid), a common light source used for PDT and the
light sources simulated in the work presented here. The irradiance of the Aktilite was
assumed to be 82 mW cm−2.
2.1. Code details
By tracking power packets (hereafter referred to as photons) on their random walk,
the light distribution is built up within the MCRT simulation volume. The power of
the source, P (W), is split among N Monte Carlo photons, giving each Monte Carlo
photon the radiant power P/N. The developed code simulates the propagation of these
photons through a 3D Cartesian grid containing voxels. The optical properties of each
voxel may be changed independently allowing both homogeneous and inhomogeneous
structures to be modelled in 3D. The grid presented here was assumed to have the
dimension of 10 mm× 10 mm× 10 mm, containing 100× 100× 100 voxels. A cylindrical
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mm. The tissue surrounding the cylindrical tumour volume was assumed to be uniform
and of single (dermis) tissue type. The mass of the tumour was conserved but for the
heterogeneous models the mass was regrouped within the cylinder to represent different
tumour structures. These will be discussed further in section 2.2.
In the code, photons are given an initial direction and wavelength and launched from
the top of the grid. It was assumed that the photons normally illuminate the surface of
the skin. The whole surface area of the tissue, including both healthy and tumour tissue
was assumed to be uniformly illuminated. The photons are subsequently followed on
their random walk through the tissue model until they are either absorbed or scattered
out of the simulation grid (figure 1 a). Absorbed photons can be re-emitted at a different
wavelength as fluorescent emission (Swartling et al., 2003; Valentine et al., 2011a; Farrell
et al., 1998), allowing the simulation of the wide field fluorescence discussed in section
2.3.
A wide range of values for the optical properties of human skin have been reported
and many of these have been summarised in recent review papers (Lister et al.,
2012a; Jacques, 2013). Here, the wavelength dependent scattering (µs) and absorption
coefficients (µa) for skin tissue and tumour tissue are the same as those used in our
previous work (Campbell et al., 2015a). The optical properties at the centre illumination
wavelength 630 nm are summarised in table 1. In the model presented here, the mass of
the tumour tissue is redistributed. The optical properties are assumed to scale linearly
with the relative redistribution. This means that the wavelength dependent scattering
and absorption coefficients of the tissue will be increased in regions hosting a higher
tumour density. Equally the initial distribution and thereby the optical properties of
the PpIX is assumed to follow the distribution of tumour tissue.
Table 1: Optical properties at 630 nm for both healthy tissue, tumour tissue and PpIX.
The optical properties for the extended wavelength range can be found in (Campbell
et al., 2015a). The tumour optical properties presented here are the optical properties
for the uniform model (fsmooth = 100%) and is scaled linearly with the relative mass
redistribution generated by the fractal models for the non-uniform tumour models.
µa µ
′
s
(cm−1) (cm−1)
Healthy tissue 0.7 36.7
Tumour tissue 2.3 21.2
PpIX 0.06 -
The Henyey-Greenstein phase function (HG(θ)) is utilised within the code to model
the angular scattering phase function (Prahl et al., 1989; Henyey and Greenstein, 1941;
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HG(θ) =
1
4pi
1− g2
(1 + g2 − 2g cos θ)3/2 (1)
where θ is the scattering angle and g is the anisotropy factor. g can take values in the
range −1 ≤ g ≤ 1, where g = 0 corresponds to isotropic scattering. Skin tissue is highly
forward scattering (g > 0) and the wavelength dependent anisotropy factor (Van Gemert
et al., 1989), g(λ) = 0.62 + 0.29× 10−3λ (with λ in nm) was adopted here. Polarisation
was not considered and the reflectance at the air/tissue interface was determined using
Fresnel reflectance assuming a uniform refractive index of 1.38 for the skin.
The concentration of the photosensitiser PpIX, and thereby the associated
absorption properties, affect the photodynamic reactions since the absorption of light
by the PpIX is necessary for the production of singlet oxygen. The initial uniform
average number density of PpIX was assumed to be 7.84×1013cm−3 corresponding to the
absorption properties shown in figure 1 b. It was assumed that the scattering caused by
PpIX was negligible. The concentration of PpIX depletes during the illumination due to
photobleaching, which depends on the fluence rate, the treatment time, the wavelength
of the illuminating light as well as the initial concentration of PpIX (Jacques et al.,
1993; Farrell et al., 1998; Valentine et al., 2011a) .The photobleaching was considered
within the MCRT code by introducing an iterative time dynamic where 106 photons
where launched during each time step. The wavelengths of the photons were sampled
such that the probability distribution function of the light spectrum (figure 1 b) was
reproduced. This number of photons (106) was implemented to ensure that good signal
to noise ratio was achieved within a reasonable simulation time. In total, 187 time steps
were adopted to simulate the full 75 J cm−2 (corresponding to 15 min of illumination).
Since the majority of the interaction occurs at the start of the treatment, the time
steps were shorter at the start of the simulated treatment. At the end of each step the
PpIX concentration was updated prior to launching a new set of photons. The following
equation was used to update the PpIX concentration (Campbell et al., 2015a),
C(x, y, z, t) = C0(x, y, z)e
−Ψ(x,y,z)t/β(λ) (2)
where C(x, y, z, t) is the local time dependent PpIX concentration, C0(x, y, z) is the
initial concentration, and Ψ(x, y, z) is the local fluence rate in W cm−2 computed in
the MCRT code. The wavelength dependent photobleaching dose constant, β(λ) was
adopted such that,
β(λ) = β(630)
µa(630)
µa(λ)
630
λ
(3)
µa(630) is the absorption coefficient of PpIX at 630 nm. β(630) corresponds to the
photobleaching dose constant at 630 nm and has previously been determined to be
14 J cm−2 (Valentine et al., 2011a). λ is the wavelength of the simulated photon in
nm and µa(λ) corresponds to the absorption coefficient for PpIX at that wavelength.
The resulting photobleaching equation assumed an unlimited oxygen supply (Valentine
6et al., 2011a; Jacques et al., 1993). The toxic threshold that is applied only considers
the average number of photons required for tissue destruction.
In the MCRT model developed here, the wavelengths of the incident photons were
chosen such that the probability distribution function of the irradiance, and therefore
the Aktilite spectrum, is reproduced (figure 1 b). The fluence rate gives the light
distribution within the skin tissue during illumination and provides information about
the light penetion depth. The photodynamic dose (PDD) is defined as the number of
photons absorbed by the photosensitiser, per unit volume (Jacques et al., 1993). It has
been suggested that the PDD is proportional to the number of singlet oxygen molecules
produced and hence can be used as an indication of the efficacy of the treatment (Farrell
et al., 1998). Within the model, absorption for both tissue as well as PpIX was included.
However, when determining the resulting PDD, only the absorption contribution from
PpIX was considered. Here we adopt a toxic threshold, indicating the number of
absorptions required for effective tissue destruction. The value 8.6× 1017 photons cm−3
has been determined from measurements of Photofrin in liver tissue (Patterson et al.,
1990), and was adopted here for illustrative purposes. To our knowledge no similar toxic
threshold has been determined for PpIX and here it was assumed that this threshold
is equally applicable to PpIX, however we acknowledge differences are possible between
Photofrin and PpIX thresholds. This allows for comparison with previously published
results (Jacques et al., 1993; Valentine et al., 2011a; Campbell et al., 2015a) as well as
between the different models explored here.
The irradiance of the light source (Aktilite) was assumed to be 82 mW cm−2 and
the estimated delivered light dose was 75 J cm−2 (Valentine et al., 2011a) (corresponding
to a treatment time of approximately 15 minutes).
2.2. Tumour model
Histological slices (Crowson, 2006) and reconstructions of 3D skin lesions such as BCC
(Scheibe et al., 2010) indicate that tumour tissue does not have a uniform structure.
Representations of these non-uniformities within the tumour was introduced by adopting
3D fractal clustered structures. By regrouping the mass of the tumour into clusters in a
fractal manner, a 3D structure was formed. The average density over the tumour region
was consistent with a smooth equivalent model with a uniform density. The structures
were generated following algorithms presented by Elmegreen (Elmegreen, 1997) and is
illustrated for a 2D case in figure 2. To determine the density of the new tumour models,
separate hierarchical levels are set up. For the first level, N1 points are cast randomly
within a 3D Cartesian grid with the x, y and z coordinates all taking values in the range
(0,1). At each subsequent level H, NH points are cast around each point generated at
level (H-1), resulting in a clustered fractal model. The distance between the points at
level H and (H-1) decreases with increasing hierarchical level. The maximum distance
from the previous level is expressed by,
±0.5∆1−H (4)
7where H is the hierarchal level and ∆ is the dimensionless casting length which is
determined through the fractal dimension such that,
fdim = log10NH/log10∆ (5)
where NH is the number of points cast at level H. Figure 2 demonstrates the basics of
the fractal structure that is built up through this routine in 2D. The points that are
cast outside of the grid of unit dimensions are cast on the other side of the grid. If,
for example a point is cast at x = 1 + ε, that point is instead given the x co-ordinate
ε, since the x-boundary is set to be 1. The resulting density is proportional to the
total number of points at the final hierarchical level cast in each voxel. In figure 2 the
number of levels is three, hence the resulting density is proportional to the number of
plus signs in each pixel (here a 5 × 5 grid system). The 3D grid of unit dimensions
is thereafter mapped to the desired density grid such that the dimensions correspond
to the simulated grid. In the case described here the clustered grid system is mapped
onto a grid system containing 100× 100× 100 voxels. The clustered structure is further
restricted to the cylindrical tumour region (figure 1 a) by eliminating points located
outside of the cylindrical volume. The density within the cylinder is scaled to ensure
that the total mass of the tumour is conserved.
A fraction, fsmooth determines the minimum density within each voxel and
represents the density that cannot be resolved within the grid. The remaining fraction
is distributed within the clustered fractal model. Hence fsmooth determines the minimum
relative density present within the tumour region. This ensures that no voxels within
the tumour region contains no mass (zero density) and thereby creating a void in the
simulation region. Hence the average density for a 100% smooth model (i.e no mass
redistribution) and for a model with a proportion of its mass redistributed is equal.
Three different tumour models were compared where fdim was varied with the aim to
investigate the importance of 3D effects as it changes for different degrees of clustering.
A larger fdim results in a wider spread of the points cast at the final level of the fractal
model. A smaller fdim results in a tighter fractal structure containing smaller regions
of higher densities. The different parameters associated with the fractal models are
summarised in table 2.
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Figure 2: Figure demonstrating the clustered fractal model in 2D. Three levels are
generated where the first level (squares) cast four random points within the 2D plane.
The subsequent level (triangles) randomly cast four points around each point generated
at the previous level, hence generating 16 new points. The third level (pluses) cast four
points around each point generated at the second level, hence generating 64 new points.
Only the points cast at the final level contribute to the resulting density grid, hence
only the number of pluses within each pixel (dashed lines) are considered (Wood et al.,
2005).
Table 2: Parameters used to generate different density structures representing different
tumour structures. These parameters were chosen to demonstrate the effects generated
by different degrees of non-uniformity. These chosen parameters generate artificial
tumour structures where the tightness of the clusters is explored.
Fractal model tumour depth fsmooth H fdim (N1, N2, N3, N4, N5)
(mm)
1 5 25 % 5 3 (16,32,32,32,32)
2 5 25 % 5 2.5 (16,32,32,32,32)
3 5 25 % 5 2 (16,32,32,32,32)
The tumour tissue was assumed to be confined within the cylindrical tumour region
and the PpIX concentration was assumed to have an initial distribution that mapped to
the redistributed tumour geometry. As we have described above, in our 3D model
the tumour structure has different optical properties from the surrounding healthy
tissue. This includes both scattering and absorption coefficients. When we develop
our fractal based tumour structures, we assume that the optical properties of the voxels
9containing tumour tissue have the properties associated with that particular tissue type.
Furthermore, we have also assumed that the optical properties of the tumour tissue
scale linearly with the density of the tumour tissue presented within a voxel. Due to the
restricted tumour area, the first level of the fractal model was forced to only cast points
within this region. The first locations (x1, y1, z1) were therefore determined as follows
x1 = 0.3 + 0.4ξ1 (6)
y1 = 0.3 + 0.4ξ2 (7)
z1 = 0.5 + 0.5ξ3 (8)
where ξ1, ξ2 and ξ3 are different random numbers, in the range (0,1). This concentrated
the redistribution of the density to the cylinder which can be argued to be a more
realistic representation than a model where the points at the first level are randomly
cast within in the entire Cartesian grid.
Figure 3 shows cross-sections in both the vertical plane and the top slice of the
density structures investigated here. Even though the cross sectional image indicates
a pixel-wide slice where the clustered feature of the tumour tissue is centred close to
the surface, this is not true throughout the generated tumour tissue. The clusters are
randomly allocated according to equations 6-8, which results in a clustered tumour
model that is distributed throughout the assumed tumour region without bias to any
particular area. Figures 4 show the relative density histograms for the tumour densities.
The histograms demonstrate the distribution of different densities over the whole tumour
region. The minimum density within the allocated area is equal to fsmooth (here kept
at 0.25). The proportion of voxels with a relative density equal to fsmooth vary for the
different models explored due to the tightness of the clusters associated with different
values for fdim.
2.3. Fluorescence
The wide field surface fluorescence image as a result of 405 nm excitation was simulated
to demonstrate what is commonly observed and/or measured clinically. The fluorescence
photons were isotropically reemitted from the absorption location and allocated a
wavelength sampled from a PpIX fluorescence spectrum characterised by two distinct
peaks at 635 nm and 705 nm (Valentine et al., 2011b). Fluorescence photons exiting the
surface of the grid were recorded and binned according to location of exit. A numerical
aperture of 0.22 was implemented allowing only photons exiting the simulation grid
within a certain cone to be included within the grid. The motivation behind using this
numerical aperture was to consider the collection efficiency associated with potential
measurement equipment such as an optical biopsy system (Nadeau et al., 2004).
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Figure 3: Figure demonstrating the density distribution of the different tumour models
explored. The left column represents a pixel wide slice in the x-z plane in the middle of
the density grid. The right column represents a pixel wide slice in the x-y plane at the
top of the grid. The difference in the tightness of the clusters is caused by the variation
of the fractal dimensions such that a) fdim = 3, b) fdim = 2.5 and c) fdim = 2. Colour
image is available in online version.
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Figure 4: Figure demonstrating the density distribution of the different tumour models
that were explored. The density was binned to demonstrate the distribution of different
densities within different tumour structures where a) fdim = 3 and fsmooth = 0.25, b)
fdim = 2.5 and fsmooth = 0.25 and c) fdim = 2 and fsmooth = 0.25.
3. Results
The fluence rates for 405, 540 and 630 nm for the three fractal models were generated
and compared to the equivalent smooth/uniform model. The resulting average fluence
rates are displayed in figure 5. All fractal models demonstrate an increase in the average
fluence rate compared to the smooth model. However fractal model 3 results in a larger
difference compared to fractal model 1 (table 2). This is explained by the difference in
density distribution, which is demonstrated by the histograms in figure 4.
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Figure 5: Average normalised fluence rate for 3D models comparing the different fractal
models (1: fdim = 3, 2: fdim = 2.5, 3: fdim = 2) for a) 405 nm b) 540 nm and c) 630
nm. These plots are normalised by the irradiance of the light source. The fluence rate
is reduced at 5 mm due to the change in optical properties between the tumour tissue
and the healthy tissue surrounding the tumour tissue.
The PDD for the different fractal models (table 2) as well as the corresponding
smooth model, using the Aktilite as the illuminating light source is shown in figure 6.
The smooth/uniform model (fsmooth = 100%) assumed an initial uniform distribution
of the tumour/PpIX equal to the average density of the fractal models. The PDD for
the smooth model (dashed line) is included in figure 6 and is equal for all three fractal
structures. The figure additionally shows the average for the fractal models (solid lines)
as well as individual vertical sample sections demonstrating the range of treatment depth
through different parts of the tumour (grey dotted lines). From the results it is clear that
fractal structure 3 (figure 6 c) demonstrates the largest difference in treatment depth
in comparison to the smooth model. For this structure an additional average simulated
treatment depth of approximately 1 mm was gained compared to the corresponding
smooth model. This fractal model is however also associated with the largest spread
when considering vertical sample sections. Here the smooth factor (fsmooth) associated
with the fractal model starts to dominate since the redistributed mass is concentrated to
smaller volumes, resulting in deeper light penetration through the lower density regions
comprised by a relative density equal to fsmooth (25%). Figure 6a however corresponds to
a fractal model where the volume containing only the smooth component (corresponding
13
to those regions with minimum relative density (0.25)) makes up only a small part of
the total tumour volume. This results in an average PDD as a function of depth that
does not differ significantly from the corresponding smooth/uniform model. However
the vertical sample sections demonstrate the range of treatment depths achieved across
the tumour region. Hence even though the average PDD is not significantly different
from the smooth model, a large fraction of the individual sample sections penetrate
deeper into the skin. Conversely a large fraction also penetrates to a shallower depth
(figure 6 a).
Figure 7 represents the PDD through a pixel wide slice in the x-y plane. The cross
section shows where the light is absorbed and demonstrates that the light penetrates
into all areas even the high density regions (figure 7 c).
The simulated wide field fluorescence for the three different fractal models is shown
in figure 8. The relative fluorescence intensity is displayed and the image comprises
fluorescence photons generated throughout the tumour that have escaped the simulated
region via scattering. The fluorscence signal appears more uniform than the cross section
of the tumour density shown in figure 3. The wide field fluorescence also demonstrates
the variation that might occur when using a small probe to measure the fluorescence
signal. The intensity of the fluorescence changes by a factor of approximately 5 over
sub-mm size scales.
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Figure 6: Photodynamic dose (PDD) for fractal structure (solid line) a ) 1(fdim = 3) b)
2 (fdim = 2.5) and c) 3 (fdim = 2) as well as the smooth model (dashed line) generated
by the Aktilite. Grey lines corresponds to the different vertical sample sections and
demonstrate a range between the highest and the lowest PDD at the surface, which
is approximately equal to a factor of a) 15, b) 30 and c) 90. The average PDD (solid
line) for the fractal model is comparatively noisy in figure c due to the larger change in
density in the vertical direction associated with this density structure (figure 3 c). In
figure c an increase in the simulated treatment depth of approximately 1 mm is noted
between the uniform and the non-uniform tumour structures.
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Figure 7: Cross section of the photodynamic dose (PDD) through the same plane shown
in the left column of figure 3 for a) 1 (fdim = 3), b) 2 (fdim = 2.5) and c)3 (fdim = 2).
Figure demonstrates the level of absorption after a delivered light dose of 75 J cm−2.
The image dimensions are 1cm on a side. Colour image is available in online version.
Figure 8: Figure of the simulated wide field fluorescence for fractal structures a) 1 (fdim
= 3), b) 2 (fdim = 2.5) and c)3 (fdim = 2). The image shows both a more uniform
fluorescence signal compared to a cross section of the density as well as a variation in
fluorescence over small distances. The image dimensions are 1cm on a side. Colour
image is available in online version.
4. Discussion
The work presented here explores the importance of including 3D tumour structures
within theoretical simulations of PDT. Most existing models only consider uniform
densities of different tissue types, however here we show that tissue with a non-uniform
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distribution affects the light penetration in tissue considerably. Different degrees of
redistribution of tumour mass were compared but the average density over the whole
tumour region was the same for all models. The results presented in this work suggest
that if there are non-uniformities within tissue, 3D effects should be considered in
theoretical models.
The different vertical sample sections demonstrate the range of the penetration
through different parts of the tumour. The spread increases as the smooth component,
fsmooth becomes more dominating. For a structure where the mass redistribution forms
tight clusters with high density, the majority of the volume is made up of the smooth
component. Hence the majority of the propagating photons will experience a medium
of lower opacity which results in larger average fluence rates deeper in the tissue. The
resulting regions of lower density of PpIX results in an insufficient PDD in these regions,
since there are not enough absorption events possible to reach the estimated threshold.
There is more absorption in regions of higher density on the other hand and consequently
a higher PDD. This explains the larger spread in PDD associated with the vertical
sample sections from fractal structure 3 compared to fractal structure 1, where the
density difference between regions is lower (figure 4).
The wide field fluorescence images (figure 8) comprise fluorescence light emitted not
only from the surface but also contributions from the tumour below the surface. The
increasing inhomogeneity of the images varies as expected between the different fractal
structures. Point measurements will vary over small distances due to the clusters of
higher densities.
The work presented here is to our knowledge the first to consider the effects of
3D tissue structure on light distributions during PDT. Even though the structures
considered are constructed from mathematical algorithms they illustrate the effects of a
non uniform distribution on the light penetration. The method of using these algorithms
also allows for easy comparison to the equivalent smooth model to assess the importance
of 3D affects. Future work should include more realistic tumour models perhaps based
on histological samples.
5. Conclusions
3D tumour structures were introduced with the purpose of theoretically studying topical
PDT. The effects of non-uniformities within the tissue were explored by including fractal
clustered tumour models. By changing the fractal dimensions of the density structures,
different degrees of redistributions were investigated. It was found that light penetration
is strongly affected by the distribution of tissue and encourages continued usage of 3D
MCRT models when studying light propagation through skin tissue.
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